Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2).
NCT07165431 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114
Last updated 2026-02-19
Summary
The principal objective of this project is to evaluate the effect of a postbiotic supplement (inactivated microorganism) on body composition and other physiological and metabolic parameters related to excess body weight in overweight or obese adult men and women, as well as to determine changes in the gut microbiota associated with these outcomes.
Specific objectives are focus on evaluate the effect of the intervention on the following parameters:
* Changes in body weight and composition.
* Changes in glucose tolerance.
* Changes in gut microbiota (metagenomics).
* Changes in urinary and serum metabolites.
* Changes in routine biochemical variables related to carbohydrate and lipid metabolism, as well as liver parameters.
* Changes in specific markers involved in obesity pathology, such as insulin, leptin, adiponectin, and cytokines MCP-1, TNF, CRP, and others.
* Adherence to the nutritional recommendations and the gummy containing postbiotic formula.
* Changes in the level of physical activity.
Target sample size is 114 subjects, including a 10% of drop out.
Participants will be allocated in two groups for 12 weeks:
* Experimental group (n=57): nutritional recommendations + postbiotic supplement/gummy.
* Placebo group (n=57): nutritional recommendations + placebo supplement/gummy.
Participants will visit the nutritional intervention unit at weeks 1 and 12. A follow-up phone call will be conducted at week 6.
Conditions
- Nutrition, Healthy
- Weight Loss
- Overweight and Obesity
Interventions
- DIETARY_SUPPLEMENT
-
Postbiotic + nutritional recommendations
Study participants will consume daily one gummy containing a postbiotic formulation, along with adherence to healthy nutritional recommendations for 12 weeks.
- DIETARY_SUPPLEMENT
-
Placebo + nutritional recommendations
Study participants will consume daily one gummy containing a placebo formulation, along with adherence to healthy nutritional recommendations for 12 weeks.
Sponsors & Collaborators
-
Clinica Universidad de Navarra, Universidad de Navarra
lead OTHER
Principal Investigators
-
Paula Aranaz, PhD · Center for Nutrition Research
-
Fermín Milagro, PhD · Center for Nutrition Research
-
Idoia Ibero, PhD · Center for Nutrition Research
-
Blanca Martínez · Center for Nutrition Research
-
María Goñi · Center for Nutrition Research
-
Salomé Pérez · Center for Nutrition Research
-
Verónica Ciaurriz · Center for Nutrition Research
-
Ana Lorente · Center for Nutrition Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-01
- Primary Completion
- 2026-05-30
- Completion
- 2026-06-30
Countries
- Spain
Study Locations
More Related Trials
-
Obex, a Nutritional Supplement, in Overweight and Obese Spanish Women
NCT01934036 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Synbiotic Supplement on the Body Mass Index of Participants With Severe Obesity
NCT02958644 ·Status: UNKNOWN ·Phase: NA
-
Effects of Obex in Overweight and Obese Patients
NCT02145442 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Probiotic Intervention on Body Weight
NCT06989177 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT06277934 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Obex® in Overweight and Obesity
NCT03541005 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants
NCT02188251 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
NCT04881760 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Patients Being Treated With Anti-obesity Medication
NCT06790160 ·Status: RECRUITING
-
Partial Meal Replacement and Inulin in Obese Women
NCT01505023 ·Status: COMPLETED ·Phase: PHASE2
-
A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295
NCT06144684 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity
NCT00367783 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults
NCT07240246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
NCT05051579 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus
NCT06532578 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
NCT04707313 ·Status: COMPLETED ·Phase: PHASE2
-
A 16-Week Study to Evaluate the Efficacy, Safety, and Tolerability of GLY-200 in Participants With Obesity
NCT06259981 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Low-Carbohydrate Diet Combined With Probiotics for Weight Loss in Male Obese Patients.
NCT04886778 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
UBT251 Injection Phase II Study (Overweight or Obesity)
NCT07177469 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese
NCT05677867 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Olibra: A 12 Week Controlled Trial
NCT01416051 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1